首页> Diabetologia: Clinical and Experimental Diabetes and Metabolism = Organ of the European Association for the Study of Diabetes (EASD)> Derived time in glycaemic range with once-weekly semaglutide vs active comparator: post hoc analysis from the SUSTAIN clinical trial programme

Derived time in glycaemic range with once-weekly semaglutide vs active comparator: post hoc analysis from the SUSTAIN clinical trial programme

导出原文传递

翻译打印收藏纠错

第一作者： Aroda, V. R.

作者： Aroda, V. R. ^[1] ; De Block, C. ^[2] ; Kaltoft, M. ^[3] ; Lawson, J. ^[4] ; Sondergaard, A. L. ; Philis-Tsimikas, A.

作者单位： Novo Nordisk AS, Soborg, Denmark ^[1] Univ Antwerp, Antwerp Univ Hosp, Antwerp, Belgium ^[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA ^[3] Scripps Whittier Diabet Inst, San Diego, CA USA ^[4]

发布时间 2021-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetologia

2021年64卷Suppl.1期

251-251页

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Derived time in glycaemic range with once-weekly semaglutide vs active comparator: post hoc analysis from the SUSTAIN clinical trial programme

Diabetologia

相似文献

同项目论文

Diabetologia

相关期刊

检索历史 清除

Derived time in glycaemic range with once-weekly semaglutide vs active comparator: post hoc analysis from the SUSTAIN clinical trial programme

Diabetologia

相似文献

同项目论文

Diabetologia

相关期刊

检索历史清除